Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-22-026266
Filing Date
2022-07-22
Accepted
2022-07-22 16:53:17
Documents
14
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A abcl-10ka_20211231.htm   iXBRL 10-K/A 85445
2 EX-31.1 abcl-ex311_7.htm EX-31.1 20974
3 EX-31.2 abcl-ex312_6.htm EX-31.2 20826
  Complete submission text file 0001564590-22-026266.txt   336224

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA abcl-20211231.xsd EX-101.SCH 5697
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE abcl-20211231_lab.xml EX-101.LAB 30398
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abcl-20211231_pre.xml EX-101.PRE 18286
8 EXTRACTED XBRL INSTANCE DOCUMENT abcl-10ka_20211231_htm.xml XML 7953
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39781 | Film No.: 221100410
SIC: 2834 Pharmaceutical Preparations